Latuda vs. Geodon

See how Latuda and Geodon compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Latuda and Geodon are both atypical antipsychotics used for schizophrenia and bipolar disorder, but Geodon carries a stronger warning for QT interval prolongation and irregular heart rhythms.

  • Latuda is taken once daily and does not require food to work, while Geodon must be taken twice daily with a substantial meal to absorb properly.

  • Latuda has FDA approval for bipolar depression, while Geodon is approved for acute mania and as an add-on for bipolar maintenance, not depression.

Latuda vs. Geodon Drug Summary

Latuda

Latuda (lurasidone) is an atypical antipsychotic approved for schizophrenia in adults and teens, and for depressive episodes linked to bipolar I disorder, either alone or with lithium or valproate. It is taken once a day as a tablet, generally with a meal.

Geodon

Geodon (ziprasidone) is an atypical antipsychotic approved for schizophrenia, acute manic or mixed episodes of bipolar I disorder, and as an add-on to lithium or valproate for bipolar maintenance. It is taken as a capsule twice daily with food, and a short-term injectable form exists for acute agitation in schizophrenia.

Latuda vs. Geodon Side Effects

Latuda

Most common
Somnolence (up to 17%)
Extrapyramidal symptoms (up to 14%)
Nausea (up to 10%)
Akathisia (up to 13%)

Geodon

Most common
Somnolence (14-20%)
Extrapyramidal symptoms (up to 31%)
Nausea (up to 12%)
Headache (13-18%)

Latuda vs. Geodon Dosage

Latuda

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 40 mg once daily Day 1
Maximum dose 20-80 mg/day If needed
Dose changes 2 increases As tolerated

Geodon

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg twice daily At the start
Maximum dose 20-80 mg twice daily If needed
Dose changes 1 increase As tolerated

Latuda vs. Geodon Indications

Latuda

Latuda is FDA-approved for schizophrenia in adults and adolescents 13 and older. It is also approved for depressive episodes tied to bipolar I disorder, used alone or added to lithium or valproate.

  • Schizophrenia (adults and teens 13+)

  • Bipolar I depression, monotherapy

  • Bipolar I depression, add-on to lithium or valproate

  • Once-daily oral tablet

Geodon

Geodon is FDA-approved for schizophrenia in adults, for acute manic or mixed episodes of bipolar I disorder on its own, and as an add-on to lithium or valproate for longer-term bipolar management. A short-acting injectable form is approved for acute agitation in schizophrenia.

  • Schizophrenia in adults

  • Acute bipolar mania or mixed episodes, monotherapy

  • Bipolar maintenance, add-on to lithium or valproate

  • Acute agitation in schizophrenia (injection)

Latuda vs. Geodon Pros and Cons

Latuda

Latuda's once-daily dosing and lack of a strict food-timing requirement can make it easier to fit into a routine. It does not carry a QT-prolongation warning, which matters for people with heart rhythm concerns or on other QT-affecting drugs.

Pros

  • Once-daily dosing, no titration needed for schizophrenia

  • FDA-approved specifically for bipolar depression

  • No boxed QT-prolongation warning

  • Approved for adolescents with schizophrenia

Cons

  • Typically costs more than Geodon at list price, roughly $1,400 to $1,800 per month without insurance, before savings programs

  • Not approved for acute bipolar mania

  • No injectable option for acute agitation

  • Akathisia and extrapyramidal symptoms are common at higher doses

Geodon

Geodon offers flexibility with both an oral capsule and a short-term injection for acute agitation, and it is approved for acute mania, not just depression. Its main trade-off is a stricter administration requirement and a more significant heart-rhythm warning.

Pros

  • Available as an injection for acute agitation in schizophrenia

  • FDA-approved for acute bipolar manic or mixed episodes

  • Lower end of list price can run cheaper than Latuda, roughly $930 to $1,900 per month without insurance, before savings programs

  • Considered lower risk for significant weight gain among atypical antipsychotics

Cons

  • Must be taken twice daily with a substantial meal (at least 500 calories) for proper absorption

  • Boxed warning for increased mortality in elderly patients with dementia-related psychosis

  • Greater capacity to prolong the QT interval than several other antipsychotics

  • Not FDA-approved for bipolar depression

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.